TABLE 1.
Genotype | Data from cell-free assaysa |
Data from cell-based assaysa |
|||||||
---|---|---|---|---|---|---|---|---|---|
Strand transfer assaysb |
LTR DNA binding assay Kd(nM) (IC95) | Infectivity |
Relative replicative capacity (IC95) (%) | FC in resistance (IC95) |
|||||
Pseudo-Vmax (%) (IC95) | Pseudo-Km (nM) (IC95) | Enzymatic efficiency (pseudo-Vmax/pseudo-Km) | Relative half-infectious titer (IC95) | Relative infectivity (%)c | DTG | BIC | |||
WT | 116 (108–125) | 24.8 (21.8–28.11) | 4.8 | 15.2 (13.1–17.2) | 1 (9.3–1.1) | 100 (83–117) | 1 (0.7–1.5) | 1 (0.8–1.2) | |
R263K | 42 (39.8–44)d | 23.4 (22.2–24.8) | 1.8 | 30.3 (23–37.6)d | 1.5 (1.3–1.7)d | 67 | 91 (79–104) | 1.9 (1–3.4) | 2.4 (2.2–2.7)d |
G118R | 17.6 (16.2–19.2)d,e | 61.5 (49–77)d,e | 0.3 | 27.7 (19.9–35.5)d | 2.8 (2.6–2.9)d,e | 36 | 34 (29–40)d,e | 10.9 (6.3–18.5)d,e | 3.9 (2–7.7)d |
G118R plus R263K | 34 (29.8–38.8)d,e,f | 110 (63–206)d,e | 0.3 | 77 (63–91)d,e,f | 3.3 (3.1–3.4)d,e,f | 30 | 10 (3–18)d,e,f | 13.9 (7.8–25.7)d,e | 33.7 (9.7–106)d,e,f |
IC95, 95% confidence interval.
Enzymatic parameters were derived from binding saturation curve fitting.
Calculated from relative half-infectious titers.
Significantly different from WT (P < 0.05).
Significantly different from R263K (P < 0.05).
Significantly different from G118R (P < 0.05).